Profil
Ulrich Dauer was the founder of 4SC AG, where he held the title of Chief Executive Officer from 1997 to 2013.
He is currently a Non-Executive Director at Atriva Therapeutics GmbH.
Dr. Dauer's former positions include Chief Executive Officer at OMEICOS Therapeutics GmbH and Ventaleon GmbH, and Chief Strategy Officer at Vectura GmbH.
He was also the Chief Executive & Financial Officer at Vivoryon Therapeutics NV from 2018 to 2021.
Dr. Dauer obtained a doctorate degree from Julius-Maximilians-Universität Würzburg.
Aktiva positioner av Ulrich Dauer
| Företag | Position | Start |
|---|---|---|
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Develops anti-tumour medicine | Direktör/Styrelseledamot | - |
Tidigare kända positioner av Ulrich Dauer
| Företag | Position | Slut |
|---|---|---|
| VIVORYON THERAPEUTICS N.V. | Verkställande Direktör | 2023-08-14 |
| 4SC AG | Verkställande Direktör | 2013-03-31 |
Ventaleon GmbH
Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Engages in the research, development, manufacture, and distribution of antiviral substances and treatments taken by inhalation | Verkställande Direktör | - |
OMEICOS Therapeutics GmbH
OMEICOS Therapeutics GmbH BiotechnologyHealth Technology Develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation | Verkställande Direktör | - |
Vectura GmbH
Vectura GmbH Miscellaneous Commercial ServicesCommercial Services Develops and manufactures aerosol inhalation systems | Företagsledare/Principal | - |
Ulrich Dauers utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
4SC AG
4SC AG BiotechnologyHealth Technology Develops drugs for cancer treatment | Health Technology |
Vivoryon Therapeutics NV
Vivoryon Therapeutics NV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company that is engaged in the research and development of new therapeutic products for the treatment of Alzheimer disease | Commercial Services |
Vectura GmbH
Vectura GmbH Miscellaneous Commercial ServicesCommercial Services Develops and manufactures aerosol inhalation systems | Commercial Services |
Julius-Maximilians-Universität Würzburg
Julius-Maximilians-Universität Würzburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OMEICOS Therapeutics GmbH
OMEICOS Therapeutics GmbH BiotechnologyHealth Technology Develops small molecules using endogenous protective mechanism for the treatment and prevention of atrial fibrillation | Health Technology |
Ventaleon GmbH
Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Engages in the research, development, manufacture, and distribution of antiviral substances and treatments taken by inhalation | Health Technology |
Atriva Therapeutics GmbH
Atriva Therapeutics GmbH BiotechnologyHealth Technology Develops anti-tumour medicine | Health Technology |
















